Dr. Rothschild is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave
Worcester, MA 01655Phone+1 508-856-5928Fax+1 508-856-4854
Summary
- Dr. Anthony Rothschild is a psychiatrist in Worcester, MA and is affiliated with UMass Memorial Medical Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 38 years. He specializes in psychopharmacology and is experienced in psychopharmacology, anxiety/anxiety disorders, mohs disorders, mood and anxiety disorders, and psychoneuroendocrinology.
Education & Training
- Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1979 - 1983
- Perelman School of Medicine at the University of PennsylvaniaClass of 1979
Certifications & Licensure
- MA State Medical License 1980 - 2025
- FL State Medical License 2017 - 2019
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Treatment-Resistant Depression Registry Start of enrollment: 2006 Jan 01
- Sustaining Remission of Psychotic Depression Start of enrollment: 2011 Oct 01
- Genomics Used to Improve DEpression Decisions Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- Predictors of attrition during acute pharmacotherapy of psychotic depression in a clinical trial.Ryma A Ihaddadene, George S Alexopoulos, Patricia Marino, Barnett S Meyers, Benoit H Mulsant
Psychiatry Research. 2024-12-01 - Health Profile Transitions and the Association With Cognitive Impairment in Older Nursing Home Residents With Suicidal Ideation.Yiyang Yuan, Adrita Barooah, Kate L Lapane, Deborah Mack, Anthony J Rothschild
International Journal of Geriatric Psychiatry. 2024-10-01 - Question: How Should I Switch From One Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin and Norepinephrine Reuptake Inhibitor (SNRI) to Another SSRI or SNRI ...Anthony J Rothschild
Journal of Clinical Psychopharmacology. 2024-08-22
Other
- Unipolar major depression with psychotic features: Acute treatmentRothschild AJ
http://www.uptodate.com/contents/unipolar-major-depression-with-psychotic-features-acute-treatment
UpToDate, Wolters Kluwer Health - 2013-04-07 - Unipolar major depression with psychotic features: Epidemiology, clinical features, assessment, and diagnosisRothschild AJ
http://www.uptodate.com/contents/unipolar-major-depression-with-psychotic-features-epidemiology-clin
UpToDate, Wolters Kluwer Health - 2013-04-02 - Unipolar major depression with psychotic features: Maintenance treatment and prognosisRothschild AJ
http://www.uptodate.com/contents/unipolar-major-depression-with-psychotic-features-maintenance-treat
UpToDate, Wolters Kluwer Health - 2011-10-12
Press Mentions
- New England Journal of MedicineOctober 2nd, 2019
- What Is High-Functioning Depression–and Could You Have It?February 7th, 2018
- Clinical Trial of Ketamine for Treatment-Resistant Depression Underway at UMass Medical SchoolApril 6th, 2017
Grant Support
- 2/4-Sustaining Remission Of Psychotic DepressionNational Institute Of Mental Health2011–2012
- Acute Pharmacotherapy Of Unipolar Psychotic DepressionNational Institute Of Mental Health2002–2006
- Cortisol Cognition Psychosis And Outcome In DepressionNational Institute Of Mental Health1995
- Cortisol Cognition Psychosis And Outcome In DepressionNational Institute Of Mental Health1994–1995
- Cortisol Cognition Psychosis &Outcome In DepressionNational Institute Of Mental Health1991–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: